Latest KFF Health News Content

Latest KFF Health News Stories

Muhammad Ali And Parkinson’s: ‘He Can Speak To People With His Heart’

Morning Briefing

Muhammad Ali, who died on Friday, was diagnosed with Parkinson’s in 1984, a disease that eventually took away his motor skills and his ability to speak clearly. The boxer has been instrumental in raising awareness of the condition.

Deployment Of Crispr Gene Editing May Unlock Vast Potential To Target Viruses

Morning Briefing

Many viruses don’t contain DNA. Instead, their genetic information is encoded in RNA, which they use to hijack the genes of their hosts. If scientists can use gene editing to target that RNA instead, they could make advances in such areas as HIV and poliovirus. In other news, families that have a child with a rare genetic condition often struggle with isolation when coping with the diagnosis.

A Hot New Trend In Oncology: Blood Tests Over Invasive Biopsies

Morning Briefing

Researchers report that these “liquid tests” — which are less painful and risky — have proven to have results that agree with a tumor biopsy. In other news, a study shows that women who take an estrogen-suppressing drug for double the time lower their risk of their cancer returning; scientists say immunotherapy is untested in patients with autoimmune diseases; and a Minnesota cancer research center celebrates its expansion.

Cancer Researchers Weigh Benefit Of Three-Drug Combinations With Resulting Higher Costs

Morning Briefing

Combination regimens hold promise for patients but could heighten tensions over the escalating expense of cancer drugs. Meanwhile, Marketplace reports on a company that is cutting deals with pharmaceutical companies to try to rein those costs.

After Turmoil, Valeant Is Under Pressure To Show Return To Normalcy With Earnings

Morning Briefing

The drugmaker will report first quarter earnings Tuesday, and analysts will be looking to see how the company plans to resume generating profit and growth without the controversial moves it used to increase prices in the past. Other drug company news comes from Pfizer’s chief executive and Martin Shkreli, the former head of Retrophin and Turing, who faces an additional charge.

Conflict Brewing In Alaska Over Whether House GOP Can Continue Medicaid Expansion Fight

Morning Briefing

Republican legislators lost their effort to derail the governor’s order to expand Medicaid in a case that went to the state Supreme Court. The House wants to appeal but hasn’t secured consent from the Senate. Meanwhile in Wyoming, a poll by researchers at the University of Wyoming finds residents support Medicaid expansion if it will help the state budget.

Clinton Facing Pressure From Sanders To Support Calif. Initiative On Drug Prices

Morning Briefing

The ballot measure would give California health agencies the ability to negotiate with pharmaceutical companies to lower drug costs for 5 million people who are on Medicaid plans and those enrolled in the HIV/AIDS drug assistance program. Also, a look at how experts are parsing Clinton’s proposal to extend Medicare to people 55 and older.